These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 8780431

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Controlled trials of inositol in psychiatry.
    Levine J.
    Eur Neuropsychopharmacol; 1997 May; 7(2):147-55. PubMed ID: 9169302
    [Abstract] [Full Text] [Related]

  • 3. Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder.
    Benjamin J, Levine J, Fux M, Aviv A, Levy D, Belmaker RH.
    Am J Psychiatry; 1995 Jul; 152(7):1084-6. PubMed ID: 7793450
    [Abstract] [Full Text] [Related]

  • 4. Fluvoxamine treatment of obsessive-compulsive disorder.
    Perse TL, Greist JH, Jefferson JW, Rosenfeld R, Dar R.
    Am J Psychiatry; 1987 Dec; 144(12):1543-8. PubMed ID: 3120604
    [Abstract] [Full Text] [Related]

  • 5. Inositol treatment of autism.
    Levine J, Aviram A, Holan A, Ring A, Barak Y, Belmaker RH.
    J Neural Transm (Vienna); 1997 Dec; 104(2-3):307-10. PubMed ID: 9203092
    [Abstract] [Full Text] [Related]

  • 6. Inositol augmentation of serotonin reuptake inhibitors in treatment-refractory obsessive-compulsive disorder: an open trial.
    Seedat S, Stein DJ.
    Int Clin Psychopharmacol; 1999 Nov; 14(6):353-6. PubMed ID: 10565802
    [Abstract] [Full Text] [Related]

  • 7. Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder.
    Palatnik A, Frolov K, Fux M, Benjamin J.
    J Clin Psychopharmacol; 2001 Jun; 21(3):335-9. PubMed ID: 11386498
    [Abstract] [Full Text] [Related]

  • 8. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
    Erzegovesi S, Guglielmo E, Siliprandi F, Bellodi L.
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
    [Abstract] [Full Text] [Related]

  • 9. Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.
    Koran LM, Gamel NN, Choung HW, Smith EH, Aboujaoude EN.
    J Clin Psychiatry; 2005 Apr; 66(4):515-20. PubMed ID: 15816795
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Double-blind, controlled trial of inositol treatment of depression.
    Levine J, Barak Y, Gonzalves M, Szor H, Elizur A, Kofman O, Belmaker RH.
    Am J Psychiatry; 1995 May; 152(5):792-4. PubMed ID: 7726322
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
    Jenike MA, Hyman S, Baer L, Holland A, Minichiello WE, Buttolph L, Summergrad P, Seymour R, Ricciardi J.
    Am J Psychiatry; 1990 Sep; 147(9):1209-15. PubMed ID: 2143637
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder.
    McDougle CJ, Goodman WK, Leckman JF, Holzer JC, Barr LC, McCance-Katz E, Heninger GR, Price LH.
    Am J Psychiatry; 1993 Apr; 150(4):647-9. PubMed ID: 8465885
    [Abstract] [Full Text] [Related]

  • 20. Laboratory response of patients with panic and obsessive-compulsive disorders to 35% CO2 challenges.
    Perna G, Bertani A, Arancio C, Ronchi P, Bellodi L.
    Am J Psychiatry; 1995 Jan; 152(1):85-9. PubMed ID: 7802126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.